My NCBI | Sign In
RSS Settings
  • Search: Favreau JT[au]

Display Settings:

Format
Sort by

Send to:

Choose Destination

    Results: 4

    1.

    Best-case series for the use of immuno-augmentation therapy and naltrexone for the treatment of cancer.

    Shekelle P, Coulter I, Hardy ML, Morton SC, Favreau JT, Gagne J, Coulter SA, Udani J, Roth EA, Jungvig LK, Newberry S, Rohr L, Ramirez LR.

    Evid Rep Technol Assess (Summ). 2003 Apr;(78):2p.. No abstract available. PMID: 12751155 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Biofeedback interventions for gastrointestinal conditions: a systematic review.

    Coulter ID, Favreau JT, Hardy ML, Morton SC, Roth EA, Shekelle P.

    Altern Ther Health Med. 2002 May-Jun;8(3):76-83.PMID: 12017503 [PubMed - indexed for MEDLINE]Related articles

    3.

    Severe hepatotoxicity associated with the dietary supplement LipoKinetix.

    Favreau JT, Ryu ML, Braunstein G, Orshansky G, Park SS, Coody GL, Love LA, Fong TL.

    Ann Intern Med. 2002 Apr 16;136(8):590-5.PMID: 11955027 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Mind-body interventions for gastrointestinal conditions.

    Hardy ML, Favreau JT, Elfenbaum PD, Morton SC, Roth EA, Genovese BJ, Shekelle PG.

    Evid Rep Technol Assess (Summ). 2001 Mar;(40):1-2. No abstract available. PMID: 11373965 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Search details

    » See more...

    Recent activity